North America Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031
Published Date : 19-Apr-2024 |
Pages: 122 |
Formats: PDF |
COVID-19 Impact on the North America Ruminant Vaccines Market
Market Overview
The North America Ruminant Vaccines Market would witness market growth of 5.9% CAGR during the forecast period (2024-2031).
The US market dominated the North America Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,257.3 million by 2031. The Canada market is experiencing a CAGR of 8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7% during (2024 - 2031).
The ruminant vaccines market refers to the segment of the veterinary pharmaceutical industry that focuses on developing, manufacturing, distributing, and selling vaccines specifically designed for ruminant species. Ruminants are a group of mammals with a unique digestive system capable of digesting plant-based diets through rumination. Common ruminant species include cattle (both beef and dairy), sheep, goats, and certain species of deer.
The vaccines are crucial in preventing and controlling a wide range of infectious diseases affecting cattle, sheep, goats, and other ruminant species. These vaccines are utilized in various applications within livestock production systems to safeguard animal health, improve production efficiency, and reduce economic losses. For example, respiratory diseases are a significant concern in ruminant production systems, particularly in intensive or confined housing environments.
With the expansion of the red meat industry in Canada, there is a heightened need for disease prevention and control measures to safeguard the health and productivity of ruminant livestock. The Canadian government states that the country's red meat sector consists of pig, lamb mutton, goat, rabbit, horse, venison, bison, and beef & veal. In 2022, the red meat business had annual shipments of $24.72 billion. There were 1,040,200 sheep and lambs as of 2019. Most of Canada's sheep are produced in Ontario, Quebec, and Alberta (72%). Sheep and lamb farm cash receipts in 2019 totaled $189 million, or 0.3% of overall agricultural cash receipts. Thus, the rising meat industry in the region is driving the market’s growth.
Free Valuable Insights: The Ruminant Vaccines Market is Predict to reach USD 5.7 Billion by 2031, at a CAGR of 6.7%
Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- Merck & Co., Inc.
- Bimeda, Inc.
- Elanco Animal Health, Inc.
- Virbac
- Ceva Sante Animale
- CZ Vaccines S.A.U. (Zendal Health S.A.)
- Indian Immunologicals Ltd. (National Dairy Development Board)
- Vaxxinova International BV (EW Group)
North America Ruminant Vaccines Market Report Segmentation
By Animal Type
- Cattle
- Sheep & Goats
By Vaccines Type
- Modified/ Attenuated Live
- Inactivated (Killed)
- Others
By Route of Administration
- Injectable
- Intranasal
By Indication
- Bovine Respiratory Diseases (BRD)
- Diarrhea/ Scours
- FMD
- Clostridial Diseases
- Leptospirosis
- BVD Infection
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of contents
Chapter 1. MarketScope & Methodology
1.1 MarketDefinition
1.2 Objectives
1.3 MarketScope
1.4 Segmentation
1.4.1 North America Ruminant Vaccines Market, by Animal Type
1.4.2 North America Ruminant Vaccines Market, by Vaccines Type
1.4.3 North America Ruminant Vaccines Market, by Route of Administration
1.4.4 North America Ruminant Vaccines Market, by Indication
1.4.5 North America Ruminant Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Marketat a Glance
2.1 Key Highlights
Chapter 3. MarketOverview
3.1 Introduction
3.1.1 Overview
3.1.1.1 MarketComposition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 MarketDrivers
3.2.2 MarketOpportunities
3.2.3 MarketRestraints
3.2.4 MarketChallenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent strategies deployed in Ruminant Vaccines Market
Chapter 5. North America Ruminant Vaccines Market by Animal Type
5.1 North America Cattle Market by Country
5.2 North America Sheep & Goats Market by Country
Chapter 6. North America Ruminant Vaccines Market by Vaccines Type
6.1 North America Modified/ Attenuated Live Market by Country
6.2 North America Inactivated (Killed) Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Ruminant Vaccines Market by Route of Administration
7.1 North America Injectable Market by Country
7.2 North America Intranasal Market by Country
Chapter 8. North America Ruminant Vaccines Market by Indication
8.1 North America Bovine Respiratory Diseases (BRD) Market by Country
8.2 North America Diarrhea/ Scours Market by Country
8.3 North America FMD Market by Country
8.4 North America Clostridial Diseases Market by Country
8.5 North America Leptospirosis Market by Country
8.6 North America BVD Infection Market by Country
8.7 North America Others Market by Country
Chapter 9. North America Ruminant Vaccines Market by Country
9.1 US Ruminant Vaccines Market
9.1.1 US Ruminant Vaccines Market by Animal Type
9.1.2 US Ruminant Vaccines Market by Vaccines Type
9.1.3 US Ruminant Vaccines Market by Route of Administration
9.1.4 US Ruminant Vaccines Market by Indication
9.2 Canada Ruminant Vaccines Market
9.2.1 Canada Ruminant Vaccines Market by Animal Type
9.2.2 Canada Ruminant Vaccines Market by Vaccines Type
9.2.3 Canada Ruminant Vaccines Market by Route of Administration
9.2.4 Canada Ruminant Vaccines Market by Indication
9.3 Mexico Ruminant Vaccines Market
9.3.1 Mexico Ruminant Vaccines Market by Animal Type
9.3.2 Mexico Ruminant Vaccines Market by Vaccines Type
9.3.3 Mexico Ruminant Vaccines Market by Route of Administration
9.3.4 Mexico Ruminant Vaccines Market by Indication
9.4 Rest of North America Ruminant Vaccines Market
9.4.1 Rest of North America Ruminant Vaccines Market by Animal Type
9.4.2 Rest of North America Ruminant Vaccines Market by Vaccines Type
9.4.3 Rest of North America Ruminant Vaccines Market by Route of Administration
9.4.4 Rest of North America Ruminant Vaccines Market by Indication
Chapter 10. Company Profiles
10.1 Boehringer Ingelheim International GmbH
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional & Segmental Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Product Launches and Product Expansions:
10.1.5.3 Geographical Expansions:
10.1.6 SWOT Analysis
10.2 Zoetis, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Merck & Co., Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Bimeda, Inc.
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Elanco Animal Health, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Virbac
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional Analysis
10.6.4 SWOT Analysis
10.7 Ceva Sante Animale
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Acquisition and Mergers:
10.7.3 SWOT Analysis
10.8 CZ Vaccines S.A.U. (Zendal Health S.A.)
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Indian Immunologicals Ltd. (National Dairy Development Board)
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.9.4 SWOT Analysis
10.10. Vaxxinova International BV (EW Group)
10.10.1 Company Overview
10.10.2 SWOT Analysis
1.1 MarketDefinition
1.2 Objectives
1.3 MarketScope
1.4 Segmentation
1.4.1 North America Ruminant Vaccines Market, by Animal Type
1.4.2 North America Ruminant Vaccines Market, by Vaccines Type
1.4.3 North America Ruminant Vaccines Market, by Route of Administration
1.4.4 North America Ruminant Vaccines Market, by Indication
1.4.5 North America Ruminant Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Marketat a Glance
2.1 Key Highlights
Chapter 3. MarketOverview
3.1 Introduction
3.1.1 Overview
3.1.1.1 MarketComposition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 MarketDrivers
3.2.2 MarketOpportunities
3.2.3 MarketRestraints
3.2.4 MarketChallenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent strategies deployed in Ruminant Vaccines Market
Chapter 5. North America Ruminant Vaccines Market by Animal Type
5.1 North America Cattle Market by Country
5.2 North America Sheep & Goats Market by Country
Chapter 6. North America Ruminant Vaccines Market by Vaccines Type
6.1 North America Modified/ Attenuated Live Market by Country
6.2 North America Inactivated (Killed) Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Ruminant Vaccines Market by Route of Administration
7.1 North America Injectable Market by Country
7.2 North America Intranasal Market by Country
Chapter 8. North America Ruminant Vaccines Market by Indication
8.1 North America Bovine Respiratory Diseases (BRD) Market by Country
8.2 North America Diarrhea/ Scours Market by Country
8.3 North America FMD Market by Country
8.4 North America Clostridial Diseases Market by Country
8.5 North America Leptospirosis Market by Country
8.6 North America BVD Infection Market by Country
8.7 North America Others Market by Country
Chapter 9. North America Ruminant Vaccines Market by Country
9.1 US Ruminant Vaccines Market
9.1.1 US Ruminant Vaccines Market by Animal Type
9.1.2 US Ruminant Vaccines Market by Vaccines Type
9.1.3 US Ruminant Vaccines Market by Route of Administration
9.1.4 US Ruminant Vaccines Market by Indication
9.2 Canada Ruminant Vaccines Market
9.2.1 Canada Ruminant Vaccines Market by Animal Type
9.2.2 Canada Ruminant Vaccines Market by Vaccines Type
9.2.3 Canada Ruminant Vaccines Market by Route of Administration
9.2.4 Canada Ruminant Vaccines Market by Indication
9.3 Mexico Ruminant Vaccines Market
9.3.1 Mexico Ruminant Vaccines Market by Animal Type
9.3.2 Mexico Ruminant Vaccines Market by Vaccines Type
9.3.3 Mexico Ruminant Vaccines Market by Route of Administration
9.3.4 Mexico Ruminant Vaccines Market by Indication
9.4 Rest of North America Ruminant Vaccines Market
9.4.1 Rest of North America Ruminant Vaccines Market by Animal Type
9.4.2 Rest of North America Ruminant Vaccines Market by Vaccines Type
9.4.3 Rest of North America Ruminant Vaccines Market by Route of Administration
9.4.4 Rest of North America Ruminant Vaccines Market by Indication
Chapter 10. Company Profiles
10.1 Boehringer Ingelheim International GmbH
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional & Segmental Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Product Launches and Product Expansions:
10.1.5.3 Geographical Expansions:
10.1.6 SWOT Analysis
10.2 Zoetis, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Merck & Co., Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Bimeda, Inc.
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Elanco Animal Health, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Virbac
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional Analysis
10.6.4 SWOT Analysis
10.7 Ceva Sante Animale
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Acquisition and Mergers:
10.7.3 SWOT Analysis
10.8 CZ Vaccines S.A.U. (Zendal Health S.A.)
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Indian Immunologicals Ltd. (National Dairy Development Board)
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.9.4 SWOT Analysis
10.10. Vaxxinova International BV (EW Group)
10.10.1 Company Overview
10.10.2 SWOT Analysis
List of Tables
TABLE 1 North America Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 2 North America Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 3 North America Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 4 North America Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 5 North America Cattle Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Cattle Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Sheep & Goats Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Sheep & Goats Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 10 North America Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 11 North America Modified/ Attenuated Live Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Modified/ Attenuated Live Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 18 North America Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 19 North America Injectable Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Injectable Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Intranasal Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Intranasal Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 24 North America Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 25 North America Bovine Respiratory Diseases (BRD) Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Bovine Respiratory Diseases (BRD) Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Diarrhea/ Scours Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Diarrhea/ Scours Market by Country, 2024 - 2031, USD Million
TABLE 29 North America FMD Market by Country, 2020 - 2023, USD Million
TABLE 30 North America FMD Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Clostridial Diseases Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Clostridial Diseases Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Leptospirosis Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Leptospirosis Market by Country, 2024 - 2031, USD Million
TABLE 35 North America BVD Infection Market by Country, 2020 - 2023, USD Million
TABLE 36 North America BVD Infection Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Ruminant Vaccines Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Ruminant Vaccines Market by Country, 2024 - 2031, USD Million
TABLE 41 US Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 42 US Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 43 US Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 44 US Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 45 US Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 46 US Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 47 US Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 48 US Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 49 US Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 50 US Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 51 Canada Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 52 Canada Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 53 Canada Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 54 Canada Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 55 Canada Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 56 Canada Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 57 Canada Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 58 Canada Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 59 Canada Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 60 Canada Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 61 Mexico Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 62 Mexico Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 63 Mexico Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 64 Mexico Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 65 Mexico Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 66 Mexico Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 67 Mexico Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 68 Mexico Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 69 Mexico Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 70 Mexico Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 71 Rest of North America Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 72 Rest of North America Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 73 Rest of North America Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 74 Rest of North America Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 75 Rest of North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 76 Rest of North America Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 77 Rest of North America Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 78 Rest of North America Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 79 Rest of North America Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 80 Rest of North America Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 81 Key Information – Boehringer Ingelheim International GmbH
TABLE 82 Key Information – Zoetis, Inc.
TABLE 83 Key Information - Merck & Co., Inc.
TABLE 84 Key Information – Bimeda, Inc.
TABLE 85 Key information – Elanco Animal Health, Inc.
TABLE 86 Key Information – Virbac
TABLE 87 Key Information – Ceva SantE Animale
TABLE 88 Key Information – CZ Vaccines S.A.U.
TABLE 89 Key Information – Indian Immunologicals Ltd.
TABLE 90 Key Information – Vaxxinova International BV
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Ruminant Vaccines Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Ruminant Vaccines Market
FIG 4 Porter’s Five Forces Analysis - Ruminant Vaccines Market
FIG 5 North America Ruminant Vaccines Marketshare by Animal Type, 2023
FIG 6 North America Ruminant Vaccines Marketshare by Animal Type, 2031
FIG 7 North America Ruminant Vaccines Market by Animal Type, 2020 - 2031, USD Million
FIG 8 North America Ruminant Vaccines Marketshare by Vaccines Type, 2023
FIG 9 North America Ruminant Vaccines Marketshare by Vaccines Type, 2031
FIG 10 North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2031, USD Million
FIG 11 North America Ruminant Vaccines Marketshare by Route of Administration, 2023
FIG 12 North America Ruminant Vaccines Marketshare by Route of Administration, 2031
FIG 13 North America Ruminant Vaccines Market by Route of Administration, 2020 - 2031, USD Million
FIG 14 North America Ruminant Vaccines Marketshare by Indication, 2023
FIG 15 North America Ruminant Vaccines Marketshare by Indication, 2031
FIG 16 North America Ruminant Vaccines Market by Indication, 2020 - 2031, USD Million
FIG 17 North America Ruminant Vaccines Marketshare by Country, 2023
FIG 18 North America Ruminant Vaccines Marketshare by Country, 2031
FIG 19 North America Ruminant Vaccines Market by Country, 2020 - 2031, USD Million
FIG 20 Recent strategies and developments: Boehringer Ingelheim International GmbH
FIG 21 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 22 Swot Analysis: ZOETIS, INC.
FIG 23 SWOT Analysis: Merck & Co., Inc.
FIG 24 SWOT Analysis: Bimeda, Inc.
FIG 25 SWOT Analysis: Elanco Animal Health, Inc.
FIG 26 SWOT Analysis: Virbac
FIG 27 SWOT Analysis: Ceva Sante Animale
FIG 28 SWOT Analysis: CZ Vaccines S.A.U.
FIG 29 SWOT Analysis: Indian Immunologicals Ltd.
FIG 30 SWOT Analysis: Vaxxinova International BV
TABLE 2 North America Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 3 North America Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 4 North America Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 5 North America Cattle Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Cattle Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Sheep & Goats Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Sheep & Goats Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 10 North America Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 11 North America Modified/ Attenuated Live Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Modified/ Attenuated Live Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 18 North America Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 19 North America Injectable Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Injectable Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Intranasal Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Intranasal Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 24 North America Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 25 North America Bovine Respiratory Diseases (BRD) Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Bovine Respiratory Diseases (BRD) Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Diarrhea/ Scours Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Diarrhea/ Scours Market by Country, 2024 - 2031, USD Million
TABLE 29 North America FMD Market by Country, 2020 - 2023, USD Million
TABLE 30 North America FMD Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Clostridial Diseases Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Clostridial Diseases Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Leptospirosis Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Leptospirosis Market by Country, 2024 - 2031, USD Million
TABLE 35 North America BVD Infection Market by Country, 2020 - 2023, USD Million
TABLE 36 North America BVD Infection Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Ruminant Vaccines Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Ruminant Vaccines Market by Country, 2024 - 2031, USD Million
TABLE 41 US Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 42 US Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 43 US Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 44 US Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 45 US Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 46 US Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 47 US Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 48 US Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 49 US Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 50 US Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 51 Canada Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 52 Canada Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 53 Canada Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 54 Canada Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 55 Canada Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 56 Canada Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 57 Canada Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 58 Canada Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 59 Canada Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 60 Canada Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 61 Mexico Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 62 Mexico Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 63 Mexico Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 64 Mexico Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 65 Mexico Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 66 Mexico Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 67 Mexico Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 68 Mexico Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 69 Mexico Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 70 Mexico Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 71 Rest of North America Ruminant Vaccines Market, 2020 - 2023, USD Million
TABLE 72 Rest of North America Ruminant Vaccines Market, 2024 - 2031, USD Million
TABLE 73 Rest of North America Ruminant Vaccines Market by Animal Type, 2020 - 2023, USD Million
TABLE 74 Rest of North America Ruminant Vaccines Market by Animal Type, 2024 - 2031, USD Million
TABLE 75 Rest of North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2023, USD Million
TABLE 76 Rest of North America Ruminant Vaccines Market by Vaccines Type, 2024 - 2031, USD Million
TABLE 77 Rest of North America Ruminant Vaccines Market by Route of Administration, 2020 - 2023, USD Million
TABLE 78 Rest of North America Ruminant Vaccines Market by Route of Administration, 2024 - 2031, USD Million
TABLE 79 Rest of North America Ruminant Vaccines Market by Indication, 2020 - 2023, USD Million
TABLE 80 Rest of North America Ruminant Vaccines Market by Indication, 2024 - 2031, USD Million
TABLE 81 Key Information – Boehringer Ingelheim International GmbH
TABLE 82 Key Information – Zoetis, Inc.
TABLE 83 Key Information - Merck & Co., Inc.
TABLE 84 Key Information – Bimeda, Inc.
TABLE 85 Key information – Elanco Animal Health, Inc.
TABLE 86 Key Information – Virbac
TABLE 87 Key Information – Ceva SantE Animale
TABLE 88 Key Information – CZ Vaccines S.A.U.
TABLE 89 Key Information – Indian Immunologicals Ltd.
TABLE 90 Key Information – Vaxxinova International BV
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Ruminant Vaccines Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Ruminant Vaccines Market
FIG 4 Porter’s Five Forces Analysis - Ruminant Vaccines Market
FIG 5 North America Ruminant Vaccines Marketshare by Animal Type, 2023
FIG 6 North America Ruminant Vaccines Marketshare by Animal Type, 2031
FIG 7 North America Ruminant Vaccines Market by Animal Type, 2020 - 2031, USD Million
FIG 8 North America Ruminant Vaccines Marketshare by Vaccines Type, 2023
FIG 9 North America Ruminant Vaccines Marketshare by Vaccines Type, 2031
FIG 10 North America Ruminant Vaccines Market by Vaccines Type, 2020 - 2031, USD Million
FIG 11 North America Ruminant Vaccines Marketshare by Route of Administration, 2023
FIG 12 North America Ruminant Vaccines Marketshare by Route of Administration, 2031
FIG 13 North America Ruminant Vaccines Market by Route of Administration, 2020 - 2031, USD Million
FIG 14 North America Ruminant Vaccines Marketshare by Indication, 2023
FIG 15 North America Ruminant Vaccines Marketshare by Indication, 2031
FIG 16 North America Ruminant Vaccines Market by Indication, 2020 - 2031, USD Million
FIG 17 North America Ruminant Vaccines Marketshare by Country, 2023
FIG 18 North America Ruminant Vaccines Marketshare by Country, 2031
FIG 19 North America Ruminant Vaccines Market by Country, 2020 - 2031, USD Million
FIG 20 Recent strategies and developments: Boehringer Ingelheim International GmbH
FIG 21 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 22 Swot Analysis: ZOETIS, INC.
FIG 23 SWOT Analysis: Merck & Co., Inc.
FIG 24 SWOT Analysis: Bimeda, Inc.
FIG 25 SWOT Analysis: Elanco Animal Health, Inc.
FIG 26 SWOT Analysis: Virbac
FIG 27 SWOT Analysis: Ceva Sante Animale
FIG 28 SWOT Analysis: CZ Vaccines S.A.U.
FIG 29 SWOT Analysis: Indian Immunologicals Ltd.
FIG 30 SWOT Analysis: Vaxxinova International BV